Date |
Title |
---|---|
Apr 5, 2023 | ILiAD Biotechnologies Announces Presentation at the World Vaccine Congress |
Mar 10, 2023 | ILiAD Biotechnologies Announces Publication of BPZE1 Adult Phase 2b Clinical Results in The Lancet |
Sep 6, 2022 | ILiAD Biotechnologies Announces $42.8M Financing Round to Advance BPZE1 Pertussis Vaccine |
Jun 27, 2022 | |
Apr 26, 2022 | |
Jan 3, 2022 | FDA Grants ILiAD Biotechnologies Fast Track Designation for Next Generation Pertussis Vaccine BPZE1 |
Dec 17, 2021 | |
Sep 29, 2021 | |
Oct 21, 2020 | |
Sep 29, 2020 | |
Sep 24, 2020 | |
Nov 19, 2019 | |
Oct 8, 2019 | |
Jun 25, 2019 | |
Dec 19, 2018 | |
May 15, 2018 | |
July 5, 2017 | |
February 19, 2016 | Phase 1b Clinical Trial of BPZE1 Pertussis Vaccine Completes Enrollment of Randomized Study Groups |
January 8, 2014 |